Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

    NIH supports phased research to identify and validate modifiable mechanisms and therapeutic targets for central nervous system complications in people with HIV; clinical trials are not allowed.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

    Research grant for studying biological, behavioral, and social factors impacting HIV pathogenesis within NIDDK's mission and NIH priorities.

    HHS-NIH11Due Feb 16, 2027$275,000

    Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV AIDS Research (U42 Clinical Trial Not Allowed)

    This grant funds development and integration of human-based research methods and supports high-quality animal models to advance HIV/AIDS research while reducing animal use where possible.

    HHS-NIH11Forecasted Jan 25, 2027$2,725,311Forecasted

    Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)

    NIH supports large-scale implementation research to improve adoption and reach of evidence-based HIV prevention, treatment, and care in U.S. communities significantly impacted by HIV.

    HHS-NIH11Due Jun 21, 2027

    High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

    This grant supports innovative research at the HIV and substance use intersection, focusing on new avenues for prevention, treatment, and cure among people who use drugs.

    HHS-NIH11Due Feb 3, 2027$9,000,000

    Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

    Funding for early-stage trials testing drugs or devices for mental disorder treatment, focusing on clinical effects and underlying mechanisms.

    HHS-NIH11Due Jan 18, 2027